Biological and hormonal markers or chlamydia, human papillomavirus, and bacterial vaginosis among adolescents attending genitourinary medicine clinics

Sexually Transmitted Infections

Volumn 81, Issue 2, 2005, Pages 128-132

  Brabin, L ^a,b   Fairbrother, E ^b   Mandal, D ^c   Roberts, S A ^b   Higgins, S P ^d   Chandiok, S ^e   Wood, P ^f   Barnard, G ^g   Kitchener, H C ^b  

^a ST MARY S HOSPITAL   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

^c MANCHESTER ROYAL INFIRMARY   (United Kingdom)

^d NORTH MANCHESTER GENERAL HOSPITAL   (United Kingdom)

^e WITHINGTON HOSPITAL   (United Kingdom)

^f UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^g UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; ESTRONE GLUCURONIDE; HORMONE; PREGNANEDIOL; PREGNANEDIOL GLUCURONIDE; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AMENORRHEA; ANOVULATION; ARTICLE; BEHAVIOR; CHLAMYDIA; CONTRACEPTION; CORRELATION ANALYSIS; DISEASE ASSOCIATION; DISEASE MARKER; FEMALE; GENITAL TRACT INFECTION; HIGH RISK POPULATION; HUMAN; INFECTION SENSITIVITY; MAJOR CLINICAL STUDY; MENARCHE; MENSTRUATION; OLIGOMENORRHEA; PAPILLOMA VIRUS; PRIORITY JOURNAL; RACE DIFFERENCE; RISK ASSESSMENT; RISK FACTOR; SMOKING; SUPERINFECTION; VAGINITIS;

ADOLESCENT; BIOLOGICAL MARKERS; CHLAMYDIA INFECTIONS; CHLAMYDIA TRACHOMATIS; CROSS-SECTIONAL STUDIES; ESTRONE; FEMALE; HUMANS; MENSTRUAL CYCLE; NEISSERIA GONORRHOEAE; PAPILLOMAVIRUS INFECTIONS; PREGNANEDIOL; RISK ASSESSMENT; RISK FACTORS; SEXUAL BEHAVIOR; STATISTICS; VAGINOSIS, BACTERIAL;

EID: 17144409057     PISSN: 13684973     EISSN: None     Source Type: Journal    
DOI: 10.1136/sti.2004.010223     Document Type: Article

References (29)

1. PHLS Communicable Diseases Surveillance Centre. Sexual health in Britain. London, 2002 July.
2. Johnson AM, Mercer CH, Erens B, et al. Sexual behaviour in Britain: partnerships, practices and HIV risk behaviours. Lancet 2001;358:1135-42.
3. Bunnell RE, Dahlberg L, Rolfs R, et al. High prevalence and incidence of sexually transmitted diseases in urban adolescent females despite moderate risk behaviors. J Infect Dis 1999;180:1624-31.
4. Apter D. Development of the hypothalamic-pituitary-ovarian axis. Ann N Y Acad Sci 1997;816:9-21.
5. Moscicki A-B, Ma Y, Holland C, et al. Cervical ectopy in adolescent girls with and without human immunodeficiency virus. J Infect Dis 2001;183:865-70.
6. Kutteh WH, Moldoveanu Z, Mestecky J. Mucosal immunity in the female reproductive tract: correlation of immunoglobulins, cytokines and reproductive hormones in human cervical mucus around the time of ovulation. AIDS Res Hum Retroviruses 1998;14:S51-5.
7. Baeten JM, Nyange PM, Richardson BA, et al. Hormonal contraception and risk of STD acquisition: results from a prospective study. Am J Obstet Gynecol 2001;185:380-5.
8. Brabin L. Hormonal markers of susceptibility to sexually transmitted infections: are we taking them seriously? BMJ 2001;323:394-5.
9. Duke PM, Litt IF, Gross RT. Adolescent self assessment of sexual maturation. Pediatrics 1980;66:918-20.
10. Wilcox MH, Reynolds MT, Hoy CM, et al. Combined cervical swab and urine specimens for PCR diagnosis of Chlamydia trachomatis infection. Sex Transm Infect 2000;76:177-78.
11. Behre HM, Kuhlage J, Gaßner C, et al. Prediction of ovulation by urinary hormone measurements with the home use ClearPlan fertility monitor: comparison with transvaginal ultrasound scans and serum hormone measurements. Hum Reprod 2000;15:2478-82.
12. De Roda Hunsman AM, Walboomers JAAM, Van den Brule AJC, et al. The use of general primers GP5 and GP6 elongated at their 3′ ends with adjacent highly conserved sequences improves human papillomavirus detection by PCR. J Gen Virol 1995;76:1057-62.
13. Mclaughlan JM, Seth R, Vautier G, et al. Interleukin-8 and inducible nitric oxide synthase mRNA levels in inflammatory bowel disease at first presentation. J Pathol 1997;181:87-92.
14. Kesner JS, Knecht EA, Krieg EF, et al. Validations of time-resolved fluoroimmunoassays for urinary estrone 3-glucuronide and pregnanediol 3-glucuronide. Steroids 1994;59:205-11.
15. Munro CJ, Stabenfeldt GT, Cragun JR, et al. Relationship of serum estradiol and progesterone concentrations to the excretion profiles of their major urinary metabolites as measured by enzyme immunoassay and radioimmunoassay. Clin Chem 1991;7:838-44.
16. Ihaka R, Gentleman R. A language for data analysis and graphics. J Comp Graph Stats 1990;5:299-314.
17. Van Hooff MHA, Voorhorst FJ, Kaptein MBH, et al. Predictive value of menstrual cycle pattern, body mass index, hormone levels and polycystic ovaries at age 15 years for oligo-amenorrhoea at age 18 years. Hum Reprod 2004;19:383-92.
18. Creighton S, Edwards S, Welch J, et al. News from the frontline: sexually transmitted infections in teenagers attending a genitourinary clinic in south east London. Sex Transm Infect 2002;78:349-51.
19. Steven-Simons C, Jamison J, McGregor JA, et al. Racial variation in vaginal pH among healthy sexually active adolescents. Sex Transm Dis 1994;21:108-72.
20. Buvé A, Weiss HA, Laga M, et al. The epidemiology of gonorrhoea, chlamydia infection and syphilis in four African cities. AIDS 2001;15(Suppl 4):S79-88.
21. Collins S, Mazloomzadeh S, Winter H, et al. High incidence of cervical human papillomavirus infection in women during their first sexual relationship. Br J Obstet Gynaecol 2002;109:96-8.
22. Jacobson DL, Peralta L, Graham NMH, et al. Histologic development of cervical ectopy. Relationship to reproductive hormones. Sex Transm Dis 2000;27:252-58.
23. Tanner JM. Growth at adolescence, 2nd ed. Oxford: Blackwell Scientific Publications, 1962.
24. Windham GC, Elkin E, Fenster L, et al. Ovarian hormones in premenopausal women: variation by demographic, reproductive and menstrual cycle characteristics. Epidemiology 2002;13:675-84.
25. Freedman DS, Khan LK, Serdula MK, et al. Relation of age at menarche to race, time period, and anthropometric dimensions. The Bogalusa Heart Study. Pediatrics 2002:110 (www.pediatrics.org/cgi/content/fall/110/4/e43).
26. Manhart LE, Koutsky LA. Do condoms prevent genital HPV infection, external genital warts or cervical neoplasia? A meta-analysis. Sex Transm Dis 2002;29:725-35.
27. Tankó LB, Christiansen C. An update on the antiestrogenic effect of smoking: a literature review with implications for researchers and practitioners. Menopause 2003;11:104-9.
28. Moscicki A-B, Shiboski S, Broering J, et al. The natural history of human papillomavirus infection as measured by repeated DNA testing in adolescent and young women. J Pediatr 1998;132:277-84.
29. Crowley-Nowick PA, Ellenberg JH, Vermund SH, et al. Cytokine profile in genital tract secretions from female adolescents: impact or human immunodeficiency virus, human papillomavirus, and other sexually transmitted pathogens. J Infect Dis 2000;181:939-45.